Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

June 30, 2017

Conditions
Irreversible Pulpitis
Interventions
DRUG

Ketorolac Tromethamine

All patients will receive standard inferior alveolar nerve block of 2% lidocaine with 1:800000 epinephrine and supplemental buccal infiltration of 0.9 mL 2% lidocaine with 1:800000 epinephrine. After five minutes, the experimental group will receive supplemental buccal infiltration of 30 mg/mL of Ketorolac Tromethamine.

DRUG

Placebo

All patients will receive standard inferior alveolar nerve block of 2% lidocaine with 1:800000 epinephrine and supplemental buccal infiltration of 0.9 mL 2% lidocaine with 1:800000 epinephrine. After five minutes, control group will receive buccal infiltration of normal saline.

Trial Locations (1)

Unknown

Dental Branch, AZad UMS, Tehran

All Listed Sponsors
lead

Azad University of Medical Sciences

OTHER

NCT02923687 - Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain | Biotech Hunter | Biotech Hunter